Sökresultat

MultiPark is proud to co-fund and support World Parkinson's Day in Lund - 11 April 2024. World Parkinson's Day (WPD) is a global healthcare event celebrated on the 11th of April every year. It brings together all of us who care about Parkinson´s disease, in different capacities, around the world. To celebrate WPD, MultiPark and Parkinson Skåne have co-organised a symposium where frontline overview

https://www.multipark.lu.se/article/world-parkinsons-day-lund - 2026-06-13

Future Faculty is proud to present the 2024 Minerva Award to Dr Laura Wisse, Associate Professor of Diagnostic Radiology at the Department of Clinical Sciences in Lund. Future Faculty is proud to present the 2024 Minerva Award to Dr Laura Wisse, Associate Professor of Diagnostic Radiology at the Department of Clinical Sciences in Lund.The Minerva award selection committee’s motivation for the choi

https://www.multipark.lu.se/article/minerva-leadership-award-winner-2024 - 2026-06-13

The Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research was established in 2012 in memory of Van Andel Institute founder Jay Van Andel, who battled Parkinson’s disease for a decade before his death in 2004. The award is given to scientists who have made outstanding contributions to Parkinson’s disease research and who have positively impacted human health. Yesterday, on

https://www.multipark.lu.se/article/anders-bjorklund-honoured-jay-van-andel-award-outstanding-achievements-parkinsons-disease-research - 2026-06-13

Future Faculty has awarded the 2024 Minerva Award to Laura Wisse, Associate Professor. Congrats to the Minerva Leadership Award, Laura Wisse, Associate Professor and PI!"Thank you, I feel very honored to receive the award as a relatively young PI and will try my best to live up to this prize in the future,  to honor good academic leadership."What do you think is a good leader?"In my opinion, a goo

https://www.multipark.lu.se/article/2024-minerva-leadership-award-good-academic-leadership-will-increase-future-success - 2026-06-13

Higher dose cohort initiated after positive early safety evaluation in Parkinson's therapy. After a positive initial safety evaluation, the pioneering STEM-PD clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing a new investigational therapy for Parkinson’s disease aimed at replacing the dopamine cells lost to the disease with healthy ones derived

https://www.multipark.lu.se/article/update-stem-pd-clinical-trial-stem-cell-based-transplant-parkinsons-disease - 2026-06-13

By analysing small microvesicles that cells release to communicate with their surroundings in the blood, researchers at Lund University map what happens in the brains of stroke patients. The study published in the scientific journal Stroke expands our understanding of stroke and opens doors to new treatment strategies.
 schemic stroke, caused by a blood clot in the brain, is the leading cause of d

https://www.multipark.lu.se/article/cell-specific-biomarkers-blood-reflect-what-happens-brain-during-stroke - 2026-06-13

Popular Science SummaryWe are all familiar with the idea that living organisms are made of atoms and molecules. But not everyone knows that one of those molecules that are crucial for our lives are proteins. And no, they aren’t just something we have to eat. Proteins are an essential molecule which form our cells, together with fat, sugars, and nucleic acids. Proteins are the workforce of the cell

https://www.multipark.lu.se/article/amyloid-oligomers-capturing-threat-between-disorder-and-order-phd-thesis-lei-ortigosa-pascual - 2026-06-13

A commercially available blood test has now been trialled in routine healthcare. “The blood test showed about 90% reliability even in primary care. This may have major implications for all those individuals who seek help for memory loss and suspected Alzheimer’s,” say the researchers at Lund University in Sweden behind the study. Alzheimer’s disease affects one in five women and one in ten men ove

https://www.multipark.lu.se/article/groundbreaking-alzheimers-blood-test-proves-highly-effective-primary-healthcare - 2026-06-13

Neuroinflammation plays a significant role in neurodegenerative disorders. That is why MultiPark researchers collaborates across research teams. ”Neuroinflammatory pathways in neurodegenerative diseases” is a new special interest group (SIG) to elucidate molecular and genetic aspects in a rapidly growing research area. Malin Wennström explains how she convenes the joint effort. Can you briefly des

https://www.multipark.lu.se/article/neuroinflammatory-pathways-neurodegenerative-diseases-special-interest-group - 2026-06-13

Digital tools within healthcare are developing faster than ever before. Therefore, MultiPark researchers gather across groups to develop implementable tools for the diagnosis and prognosis of neurodegenerative disorders. “Digital tools to reliably evaluate cognitive and neurological symptoms” is a new special interest group (SIG) convened by Maria H Nilsson. Here, she tells about the group’s visio

https://www.multipark.lu.se/article/digital-tools-evaluate-symptoms-special-interest-group - 2026-06-13

Recent discoveries have shown that it is possible to convert one cell type into another, typically by forced expression of lineage specific transcription factors. That is why MultiPark researchers with expertise in reprogramming gather across research groups. Cellular reprogramming is a new special interest group (SIG) addressing scientific and technological needs to apply these methods in researc

https://www.multipark.lu.se/article/cellular-reprogramming-special-interest-group - 2026-06-13

Breakthroughs of new pharmacological treatments requires translational research – from bench to bed. That is why MultiPark researchers gather from experimental to clinical research teams. The special interest group ”Regenerative pharmacology” fosters an integrative approach for future pharmacological developments. Karsten Ruscher explains how he convenes the joint effort. Can you shortly describe

https://www.multipark.lu.se/article/regenerative-pharmacology-special-interest-group - 2026-06-13

In the podcast series "Meet our scientists", young MultiPark researchers interview our research group leaders about their academic journey and main scientific focus. Listen to the new episode where Professor Malin Parmar describes the experimental road to the ongoing stem cell trials in Lund. I the latest episode (nr. 14), Lluís welcomes the renowned Professor Malin Parmar. She leads the different

https://www.multipark.lu.se/article/meet-our-scientists-continuation-parkinsons-revolution - 2026-06-13

Receiving grants from the Swedish Research Council is viewed as a quality mark and one of the critical steps for young scientists to establish an independent research group. Recently, five of MultiPark’s research leaders were awarded funding for their projects. This year’s support from the Swedish Research Council encouraged MultiPark’s ambition to be a multidisciplinary research area. Projects ra

https://www.multipark.lu.se/article/multipark-scientists-granted-support-swedish-research-council - 2026-06-13

Malin Parmar, professor of cellular neuroscience leading one of MultiPark's research groups, along with three researchers in Italy and Denmark, has been awarded the prestigious ERC Synergy Grant worth EUR 10 million. The four researchers aim to develop custom-made neurons from stem cells for cell therapies to treat Parkinson’s or Huntington’s disease. “We want to develop a completely new concept i

https://www.multipark.lu.se/article/erc-synergy-grant-development-custom-made-stem-cell-therapies-neurodegenerative-disorders - 2026-06-13

Patients with frontotemporal dementia often lack the ability to empathize. A study at Lund University and Karolinska Institutet has now shown that these patients do not show the same brain activity as healthy individuals when they witness the pain of others, a finding that it is hoped will increase understanding of this specific dementia disease. This is an important piece of the puzzle now fallin

https://www.multipark.lu.se/article/new-study-shows-how-dementia-affects-brains-ability-empathise - 2026-06-13

A team of international researchers led by Professor Johan Jakobsson at Lund University has secured a 52 million SEK grant from the Aligning Science Across Parkinson’s (ASAP) initiative, in partnership with the Michael J Fox Foundation to investigate how mobile genetic elements —commonly referred to as "jumping genes"—contribute to neuroinflammation and the progression of Parkinson’s disease. Jump

https://www.multipark.lu.se/article/52-million-sek-goes-uncovering-genetic-drivers-parkinsons-disease - 2026-06-13

Dear colleagues and collaborators,As we approach the end of 2024, I believe that we can look back with pride on the many things that we have achieved together this year. We would like to thank all of you for your vital contributions to our research environment, encompassing diverse roles and capacities. Next year is poised to be a particularly eventful year for MultiPark. On December 12, the Swedi

https://www.multipark.lu.se/article/seasons-greetings-multipark - 2026-06-13

Dear colleagues and collaborators,Welcome to a new year with MultiPark!Our Management group has now resumed its activities at full pace, and we are happy to share some fresh information as follows:(i) The dates for this year´s meetings of the MultiPark Board and Steering group have been set and posted under this link https://www.multipark.lu.se/about-multipark/management. We welcome Oxana Klementi

https://www.multipark.lu.se/article/kicking-year-packed-program-ahead - 2026-06-13

Don't miss the latest episode of MultiPark's podcast Meet our scientists. MultiPark's newest research group leader, Henrik Ahlenius, shares his expertise about stem cells in aging and neurodegenerative diseases. In this episode, Henrik explains the fascinating interplay between aging, neurodegenerative diseases and stem cells - critical areas of study that Henrik Ahlenius has passionately pursued

https://www.multipark.lu.se/article/meet-our-scientists-podcast-henrik-ahlenius-about-stem-cells-aging-and-neurodegeneration - 2026-06-13